The manipulation of apoptosis for cancer therapy using BH3-mimetic drugs

ST Diepstraten, MA Anderson, PE Czabotar… - Nature Reviews …, 2022 - nature.com
Apoptosis is a form of programmed cell death that is regulated by the balance between
prosurvival and proapoptotic BCL-2 protein family members. Evasion of apoptosis is a …

MCL-1 inhibitors, fast-lane development of a new class of anti-cancer agents

A Bolomsky, M Vogler, MC Köse, CA Heckman… - Journal of hematology & …, 2020 - Springer
Cell death escape is one of the most prominent features of tumor cells and closely linked to
the dysregulation of members of the Bcl-2 family of proteins. Among those, the anti-apoptotic …

ERK1/2 in immune signalling

RM Lucas, L Luo, JL Stow - Biochemical Society Transactions, 2022 - portlandpress.com
Extracellular signal-related kinases 1 and 2 (ERK1/2) are the final components of the
mitogen-activated protein kinase (MAPK) phosphorylation cascade, an integral module in a …

BRAF—A tumour-agnostic drug target with lineage-specific dependencies

AJ Hanrahan, Z Chen, N Rosen, DB Solit - Nature Reviews Clinical …, 2024 - nature.com
In June 2022, the FDA granted Accelerated Approval to the BRAF inhibitor dabrafenib in
combination with the MEK inhibitor trametinib for the treatment of adult and paediatric …

Mechanisms of acquired BRAF inhibitor resistance in melanoma: a systematic review

I Proietti, N Skroza, N Bernardini, E Tolino, V Balduzzi… - Cancers, 2020 - mdpi.com
Simple Summary Patients with advanced melanoma are often treated with v-raf murine
sarcoma viral oncogene homolog B1 (BRAF) inhibitors. Although these agents prolong life …

Understanding drug sensitivity and tackling resistance in cancer

JW Tyner, F Haderk, A Kumaraswamy, LB Baughn… - Cancer research, 2022 - AACR
Decades of research into the molecular mechanisms of cancer and the development of
novel therapeutics have yielded a number of remarkable successes. However, our ability to …

Targeting MCL-1 protein to treat cancer: opportunities and challenges

SI Tantawy, N Timofeeva, A Sarkar, V Gandhi - Frontiers in oncology, 2023 - frontiersin.org
Evading apoptosis has been linked to tumor development and chemoresistance. One
mechanism for this evasion is the overexpression of prosurvival B-cell lymphoma-2 (BCL-2) …

Bioactive NIR‐II Light‐Responsive shape memory composite based on cuprorivaite nanosheets for endometrial regeneration

C Dong, C Yang, MR Younis, J Zhang, G He… - Advanced …, 2022 - Wiley Online Library
Intrauterine adhesions (IUAs) caused by mechanical damage or infection increase the risk of
infertility in women. Although numerous physical barriers such as balloon or hydrogel are …

Discovery of a Myeloid Cell Leukemia 1 (Mcl-1) Inhibitor That Demonstrates Potent In Vivo Activities in Mouse Models of Hematological and Solid Tumors

JC Tarr, JM Salovich, M Aichinger… - Journal of Medicinal …, 2024 - ACS Publications
Myeloid cell leukemia 1 (Mcl-1) is a key regulator of the intrinsic apoptosis pathway.
Overexpression of Mcl-1 is correlated with high tumor grade, poor survival, and both intrinsic …

Executioner caspases restrict mitochondrial RNA-driven Type I IFN induction during chemotherapy-induced apoptosis

ST Killarney, R Washart, RS Soderquist, JP Hoj… - Nature …, 2023 - nature.com
During apoptosis, mitochondrial outer membrane permeabilization (MOMP) enables certain
mitochondrial matrix macromolecules to escape into the cytosol. However, the fate of …